"OneSource" Comprehensive Offering Helps Laboratories Boost Productivity and Reduce Costs

ORLANDO, Fla. -- March 10, 2003 -- PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, today announced the launch of OneSource(TM), a new business that will provide comprehensive service and support for laboratories worldwide.

"Within the life and analytical sciences marketplace, customers are seeking to streamline their supply chain through fewer, more value-added partnerships, enabling them to focus on their core competencies," said Peter Coggins, president of PerkinElmer Life and Analytical Sciences. "We have launched our OneSource Laboratory Services business in response to this emerging trend, providing our customers with the means to improve productivity and reduce costs within their laboratories."

Today's intensifying regulatory environment and an ever-increasing need for greater efficiency are both challenging the traditional instrument service model where service is viewed simply as a follow-on to an instrument purchase.

"There is an increasing demand for service partnerships that extend far beyond essential maintenance and repair of individual instruments," said John Danner, vice president and general manager, OneSource Laboratory Services Business. "In addition to the demand for higher productivity within the lab, compliance with regulatory requirements has significantly increased the complexity of installing instruments, qualifying operators, and documenting laboratory processes. By partnering with PerkinElmer OneSource, customers can take advantage of a wide range of service offerings, from on-demand repairs to validation certification to education and training. This enables customers to better focus on their core research and analytical tasks."

OneSource customers can choose from a variety of service-level agreements, with offerings including preventative maintenance, 24-hour response times, or daily on-site support. OneSource service engineers are currently engaged in numerous large-scale service partnerships, in some cases with PerkinElmer engineers residing full-time on-site with customers, performing repair, maintenance and validation of instruments provided by PerkinElmer and other suppliers.

PerkinElmer is unique among instrument vendors in its broad product scope, which ranges from basic research instruments to high-throughput drug discovery tools to environmental testing and general analytical instrumentation. The OneSource business is comprised of more than 1,000 factory-trained service professionals operating in 120 countries to service the PerkinElmer installed base of hundreds of thousands of instruments.

"Because we have expertise in nearly all technologies used in the major analytical and life science laboratories, we offer a breadth of technical competence that is unmatched in the industry," said Danner. "PerkinElmer is increasingly the service partner of choice for global pharmaceutical, chemical and environmental customers."

PerkinElmer OneSource anticipates launching new service offerings throughout the year to fully enable these comprehensive service partnerships.

For more information about PerkinElmer OneSource, contact PerkinElmer at 1-800-762-4000, or visit the OneSource Web site at www.perkinelmer.com/onesource.

Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including risks related to our debt levels, our ability to comply with the financial covenants contained in our credit agreements, a downturn in our customers' markets, our failure to introduce new products in a timely manner, risks related to our international operations, our inability to integrate acquired businesses into our existing business and to successfully combine our Life and Analytical Sciences businesses, and competition as well as other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recently filed quarterly report on Form 10-Q. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.